Targeting CD20: teaching an old dog new tricks

af Sharman, Jeff P.
Udgivet i Hematology Am Soc Hematol Educ Program (2019)

Effectiveness of Warfarin among Patients with Cancer

af Rose, Adam J., Sharman, Jeff P., Ozonoff, Al, Henault, Lori E., Hylek, Elaine M.
Udgivet 2007

A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera(®)) in Subjects with Previously Un...

af Sharman, Jeff P., Liberati, Anna Marina, Ishizawa, Kenichi, Khan, Tahira, Robbins, Jeffery, Alcasid, Ann, Rosenberg, Julie Ann, Aurer, Igor
Udgivet i BioDrugs (2019)

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression

af Irish, Jonathan M., Myklebust, June H., Alizadeh, Ash A., Houot, Roch, Sharman, Jeff P., Czerwinski, Debra K., Nolan, Garry P., Levy, Ronald
Udgivet 2010

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin

af Horwitz, Steven M., Advani, Ranjana H., Bartlett, Nancy L., Jacobsen, Eric D., Sharman, Jeff P., O’Connor, Owen A., Siddiqi, Tanya, Kennedy, Dana A., Oki, Yasuhiro
Udgivet i Blood (2014)

Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia

af Byrd, John C., Flynn, Joseph M., Kipps, Thomas J., Boxer, Michael, Kolibaba, Kathryn S., Carlile, David J., Fingerle-Rowson, Guenter, Tyson, Nicola, Hirata, Jamie, Sharman, Jeff P.
Udgivet i Blood (2016)

An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma

af Andorsky, David J., Kolibaba, Kathryn S., Assouline, Sarit, Forero‐Torres, Andres, Jones, Vicky, Klein, Leonard M., Patel‐Donnelly, Dipti, Smith, Mitchell, Ye, Wei, Shi, Wen, Yasenchak, Christopher A., Sharman, Jeff P.
Udgivet i Br J Haematol (2018)

Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin

af Coffey, Greg P., Rajapaksa, Ranjani, Liu, Raymond, Sharpe, Orr, Kuo, Chiung-Chi, Krauss, Sharon Wald, Sagi, Yael, Davis, R. Eric, Staudt, Louis M., Sharman, Jeff P., Robinson, William H., Levy, Shoshana
Udgivet 2009

Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States

af Nabhan, Chadi, Mato, Anthony, Flowers, Christopher R., Grinblatt, David L., Lamanna, Nicole, Weiss, Mark A., Davids, Matthew S., Swern, Arlene S., Bhushan, Shriya, Sullivan, Kristen, Flick, E. Dawn, Kiselev, Pavel, Sharman, Jeff P.
Udgivet i BMC Cancer (2017)

Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older

af Forero-Torres, Andres, Holkova, Beata, Goldschmidt, Jerome, Chen, Robert, Olsen, Gregg, Boccia, Ralph V., Bordoni, Rodolfo E., Friedberg, Jonathan W., Sharman, Jeff P., Palanca-Wessels, Maria Corinna, Wang, Yinghui, Yasenchak, Christopher A.
Udgivet i Blood (2015)

Ublituximab (TG‐1101), a novel glycoengineered anti‐CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymph...

af Sharman, Jeff P., Farber, Charles M., Mahadevan, Daruka, Schreeder, Marshall T., Brooks, Heather D., Kolibaba, Kathryn S., Fanning, Suzanne, Klein, Leonard, Greenwald, Daniel R., Sportelli, Peter, Miskin, Hari P., Weiss, Michael S., Burke, John M.
Udgivet i Br J Haematol (2016)

Early progression of disease as a predictor of survival in chronic lymphocytic leukemia

af Ahn, Inhye E., Farber, Charles M., Davids, Matthew S., Grinblatt, David L., Kay, Neil E., Lamanna, Nicole, Mato, Anthony, Nabhan, Chadi, Kiselev, Pavel, Swern, Arlene S., Flick, E. Dawn, Sullivan, Kristen, Sharman, Jeff P., Flowers, Christopher R.
Udgivet i Blood Adv (2017)

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

af Advani, Ranjana H., Buggy, Joseph J., Sharman, Jeff P., Smith, Sonali M., Boyd, Thomas E., Grant, Barbara, Kolibaba, Kathryn S., Furman, Richard R., Rodriguez, Sara, Chang, Betty Y., Sukbuntherng, Juthamas, Izumi, Raquel, Hamdy, Ahmed, Hedrick, Eric, Fowler, Nathan H.
Udgivet i J Clin Oncol (2013)

The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites

af Mato, Anthony, Nabhan, Chadi, Lamanna, Nicole, Kay, Neil E., Grinblatt, David L., Flowers, Christopher R., Farber, Charles M., Davids, Matthew S., Swern, Arlene S., Sullivan, Kristen, Flick, E. Dawn, Gressett Ussery, Sarah M., Gharibo, Mecide, Kiselev, Pavel, Sharman, Jeff P.
Udgivet i Blood Adv (2020)

Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

af Byrd, John C., Furman, Richard R., Coutre, Steven E., Flinn, Ian W., Burger, Jan A., Blum, Kristie, Sharman, Jeff P., Wierda, William, Zhao, Weiqiang, Heerema, Nyla A., Luan, Ying, Liu, Emily A., Dean, James P., O’Brien, Susan
Udgivet i Clin Cancer Res (2020)

Management of adverse events associated with idelalisib treatment: expert panel opinion

af Coutré, Steven E., Barrientos, Jacqueline C., Brown, Jennifer R., de Vos, Sven, Furman, Richard R., Keating, Michael J., Li, Daniel, O’Brien, Susan M., Pagel, John M., Poleski, Martin H., Sharman, Jeff P., Yao, Nai-Shun, Zelenetz, Andrew D.
Udgivet i Leuk Lymphoma (2015)

Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry

af Mato, Anthony R., Barrientos, Jacqueline C., Ghosh, Nilanjan, Pagel, John M., Brander, Danielle M., Gutierrez, Meghan, Kadish, Karen, Tomlinson, Brian, Iyengar, Reethi, Ipe, David, Upasani, Sandhya, Amaya-Chanaga, Carlos I., Sundaram, Murali, Han, Jennifer, Giafis, Nick, Sharman, Jeff P.
Udgivet i Clin Lymphoma Myeloma Leuk (2019)

Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

af Coutre, Steven E., Flinn, Ian W., de Vos, Sven, Barrientos, Jacqueline C., Schreeder, Marshall T., Wagner-Johnson, Nina D., Sharman, Jeff P., Boyd, Thomas E., Fowler, Nathan, Dreiling, Lyndah, Kim, Yeonhee, Mitra, Siddhartha, Rai, Kanti, Leonard, John P., Furman, Richard R.
Udgivet i Hemasphere (2018)

Real‐world clinical experience in the Connect(®) chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres

af Mato, Anthony, Nabhan, Chadi, Kay, Neil E., Weiss, Mark A., Lamanna, Nicole, Kipps, Thomas J., Grinblatt, David L., Flinn, Ian W., Kozloff, Mark F., Flowers, Christopher R., Farber, Charles M., Kiselev, Pavel, Swern, Arlene S., Sullivan, Kristen, Flick, E. Dawn, Sharman, Jeff P.
Udgivet i Br J Haematol (2016)

Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma

af de Vos, Sven, Wagner-Johnston, Nina D., Coutre, Steven E., Flinn, Ian W., Schreeder, Marshall T., Fowler, Nathan H., Sharman, Jeff P., Boccia, Ralph V., Barrientos, Jacqueline C., Rai, Kanti R., Boyd, Thomas E., Furman, Richard R., Kim, Yeonhee, Godfrey, Wayne R., Leonard, John P.
Udgivet i Blood Adv (2016)